Molecular basis of interferon resistance in hepatitis C virus
- 1 October 2014
- journal article
- research article
- Published by Elsevier in Current Opinion in Virology
- Vol. 8, 38-44
Abstract
No abstract availableKeywords
Funding Information
- Centro de Biología Molecular Severo Ochoa (CSIC-UAM) (BFU2011-23604)
- Instituto de Salud Carlos III
This publication has 54 references indexed in Scilit:
- Immune Responses to HCV and Other Hepatitis VirusesImmunity, 2014
- Regulation of hepatic innate immunity by hepatitis C virusNature Medicine, 2013
- Understanding the hepatitis C virus life cycle paves the way for highly effective therapiesNature Medicine, 2013
- Type 1 Interferons and Antiviral CD8 T-Cell ResponsesPLOS Pathogens, 2012
- Antiviral strategies in hepatitis C virus infectionJournal of Hepatology, 2012
- Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b–infected null respondersHepatology, 2011
- The interferon-α/β system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factorsCurrent Opinion in Immunology, 2002
- Combination of interferon and ribavirin in chronic hepatitis C: Re-treatment of nonresponders to interferonHepatology, 2001
- Interferon and Ribavirin vs Interferon Alone in the Re-treatment of Chronic Hepatitis C Previously Nonresponsive to InterferonJAMA, 2001
- Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis CNew England Journal of Medicine, 1998